|
|||||
|
|
New Feature: See Wall Street analyst ratings directly on Finviz charts for deeper context into price action.
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VFC | OTIS CLARENCE JR | Director | Jun 02 '21 | Sale | 79.56 | 13,449 | 1,069,935 | 18,893 | Jun 03 03:07 PM |
| VFC | OTIS CLARENCE JR | Director | Dec 11 '19 | Sale | 91.14 | 16,930 | 1,543,000 | 16,221 | Dec 12 05:05 PM |
| VFC | OTIS CLARENCE JR | Director | Nov 08 '17 | Sale | 69.37 | 12,552 | 870,687 | 13,501 | Nov 09 12:05 PM |
| VFC | OTIS CLARENCE JR | Director | Aug 10 '16 | Sale | 62.12 | 25,540 | 1,586,481 | 11,970 | Aug 11 11:28 AM |
| VFC | OTIS CLARENCE JR | Director | Nov 24 '14 | Sale | 73.83 | 22,852 | 1,687,161 | 9,765 | Nov 25 09:49 AM |
| VFC | OTIS CLARENCE JR | Director | Feb 20 '14 | Sale | 57.88 | 46,400 | 2,685,785 | 9,765 | Feb 21 11:07 AM |
| DRI | OTIS CLARENCE JR | Chairman, CEO | Dec 23 '13 | Sale | 53.88 | 52,500 | 2,828,564 | 250,552 | Dec 26 09:11 AM |
| DRI | OTIS CLARENCE JR | Chairman, CEO | Jul 25 '13 | Sale | 48.10 | 1 | 47 | 223,052 | Jul 26 03:51 PM |
| VFC | OTIS CLARENCE JR | Director | May 02 '12 | Sale | 155.37 | 10,200 | 1,584,753 | 1,777 | May 03 04:55 PM |
| DRI | OTIS CLARENCE JR | Chairman, CEO | Mar 27 '12 | Sale | 51.18 | 133,000 | 6,806,780 | 316,872 | Mar 29 04:00 PM |
| DRI | OTIS CLARENCE JR | Chairman, CEO | Jul 12 '11 | Sale | 52.69 | 17,570 | 925,686 | 240,641 | Jul 14 08:22 AM |
| DRI | OTIS CLARENCE JR | Chairman, CEO | Mar 26 '10 | Sale | 44.48 | 97,500 | 4,336,673 | 216,473 | Mar 30 03:17 PM |
| DRI | OTIS CLARENCE JR | Chairman, CEO | Mar 20 '09 | Sale | 34.03 | 35,525 | 1,208,742 | 204,059 | Mar 24 02:25 PM |
| DRI | OTIS CLARENCE JR | Chairman, CEO | Jan 05 '09 | Sale | 28.50 | 60,000 | 1,709,712 | 204,059 | Jan 07 03:35 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite